Hamid Reza Talari1, Somayyeh Poladchang1, Yaser Hamidian1, Mansooreh Samimi2, Hamid Reza Gilasi3, Faraneh Afshar Ebrahimi2, Zatollah Asemi4. 1. Department of Radiology, Kashan University of Medical Sciences, Kashan, Iran. 2. Department of Gynecology and Obstetrics, Kashan University of Medical Sciences, Kashan, Iran. 3. Department of Epidemiology and Biostatistics, Kashan University of Medical Sciences, Kashan, Iran. 4. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.
Abstract
OBJECTIVES: We sought to evaluate the effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness (CIMT) and inflammatory factors in patients with polycystic ovary syndrome (PCOS). METHODS: This randomized, double-blind, placebo-controlled trial was done among 60 women with PCOS. Participants were randomly assigned into two groups (n = 30 each group) and assigned to take either 1000 mg omega-3 plus 400 IU vitamin E supplements or a placebo for 12 weeks. RESULTS: Compared with placebo, omega-3 and vitamin E co-supplementation led to significant decreases in maximum levels of left CIMT (-0.006±0.006 vs. +0.002±0.007 mm, p < 0.001), mean levels of left CIMT (-0.005±0.006 vs. +0.002±0.010 mm, p = 0.010), maximum levels of right CIMT (-0.006±0.010 vs. +0.006±0.010 mm, p = 0.010), and mean levels of right CIMT (-0.005±0.005 vs. +0.001±0.010 mm, p = 0.020). Change in high-sensitivity C-reactive protein (hs-CRP) (-390.6±942.9 vs. +237.0±754.3 ng/mL, p = 0.006) was significantly different between the supplemented patients and placebo group. We did not observe any significant effect in plasma nitric oxide (NO) values following supplementation with omega-3 plus vitamin E compared with the placebo. CONCLUSIONS: Co-supplementation with omega-3 and vitamin E for 12 weeks among patients with PCOS had beneficial effects on CIMT and serum hs-CRP values, but unchanged NO values.
OBJECTIVES: We sought to evaluate the effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness (CIMT) and inflammatory factors in patients with polycystic ovary syndrome (PCOS). METHODS: This randomized, double-blind, placebo-controlled trial was done among 60 women with PCOS. Participants were randomly assigned into two groups (n = 30 each group) and assigned to take either 1000 mg omega-3 plus 400 IU vitamin E supplements or a placebo for 12 weeks. RESULTS: Compared with placebo, omega-3 and vitamin E co-supplementation led to significant decreases in maximum levels of left CIMT (-0.006±0.006 vs. +0.002±0.007 mm, p < 0.001), mean levels of left CIMT (-0.005±0.006 vs. +0.002±0.010 mm, p = 0.010), maximum levels of right CIMT (-0.006±0.010 vs. +0.006±0.010 mm, p = 0.010), and mean levels of right CIMT (-0.005±0.005 vs. +0.001±0.010 mm, p = 0.020). Change in high-sensitivity C-reactive protein (hs-CRP) (-390.6±942.9 vs. +237.0±754.3 ng/mL, p = 0.006) was significantly different between the supplemented patients and placebo group. We did not observe any significant effect in plasma nitric oxide (NO) values following supplementation with omega-3 plus vitamin E compared with the placebo. CONCLUSIONS: Co-supplementation with omega-3 and vitamin E for 12 weeks among patients with PCOS had beneficial effects on CIMT and serum hs-CRP values, but unchanged NO values.
Authors: Elsa M Hjerkinn; Michael Abdelnoor; Liv Breivik; Lise Bergengen; Ingrid Ellingsen; Ingebjørg Seljeflot; Ottar Aase; Tor Ole Klemsdal; Ingvar Hjermann; Harald Arnesen Journal: Eur J Cardiovasc Prev Rehabil Date: 2006-06
Authors: Howard N Hodis; Wendy J Mack; Laurie LaBree; Peter R Mahrer; Alex Sevanian; Chao-ran Liu; Ci-hua Liu; Juliana Hwang; Robert H Selzer; Stanley P Azen Journal: Circulation Date: 2002-09-17 Impact factor: 29.690
Authors: Jasmina Djedjibegovic; Aleksandra Marjanovic; Ilhana Kobilica; Amila Turalic; Aida Lugusic; Miroslav Sober Journal: AIMS Public Health Date: 2020-07-08